{
    "2020-12-29": [
        [
            {
                "time": "",
                "original_text": "大参林(603233.SH)：控股股东及一致行动人减持140.5万张“大参转债” 减持股份",
                "features": {
                    "keywords": [
                        "大参林",
                        "控股股东",
                        "一致行动人",
                        "减持",
                        "大参转债"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "大参林：控股股东的一致行动人累计减持“大参转债”140.5万张 减持股份",
                "features": {
                    "keywords": [
                        "大参林",
                        "控股股东",
                        "一致行动人",
                        "减持",
                        "大参转债"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：海外疫情引关注 “国谈”下创新药企业面临新考验",
                "features": {
                    "keywords": [
                        "医药行业",
                        "海外疫情",
                        "国谈",
                        "创新药企业",
                        "考验"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药周报：板块温和向上 精选质地优良、增长确定性强的血制品、药店、检测和类消费生物药",
                "features": {
                    "keywords": [
                        "医药周报",
                        "板块温和向上",
                        "血制品",
                        "药店",
                        "检测",
                        "类消费生物药"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}